We also reported that reduced ER acetylation, as observed in AT-1 hypomorphic (AT-1S113R/+) mice or following ATase1/ATase2 inhibition by Compound 9, can resolve the proteopathy associated with the AD-like phenotype of APP695/swe mice9. Here, SLC33A1 is linked to Alzheimer disease.